Barclays PLC Sponsored ADR logo

Barclays PLC Sponsored ADR (BCS)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
24. 69
-0.59
-2.33%
$
83.53B Market Cap
- P/E Ratio
0.27% Div Yield
4,505,923 Volume
- Eps
$ 25.28
Previous Close
Add Transaction
Day Range
24.59 25.01
Year Range
17.22 27.7
Want to track BCS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bullish On Barclays Again, As It Stands Out Among Europe's Global Diversified Banks

Bullish On Barclays Again, As It Stands Out Among Europe's Global Diversified Banks

Barclays is reaffirmed as a buy, standing out for strong fundamentals, performance vs. similar banks, attractive valuation, and upside forecasts despite macro headwinds. BCS demonstrated robust top-line growth, peer-leading margins, and global business diversification, with notable momentum in investment banking and US consumer lending. Balance sheet risk is balanced by strong credit ratings and stable asset quality, though high leverage and private credit exposure warrant monitoring.

Seekingalpha | 2 months ago
Phathom Pharmaceuticals Upgraded by Barclays to Overweight With $18 Target

Phathom Pharmaceuticals Upgraded by Barclays to Overweight With $18 Target

Barclays analyst Jenna Davidner upgraded Phathom Pharmaceuticals (NASDAQ:PHAT) to Overweight from Equal Weight on Friday, raising her price target to $18 from $16.

247wallst | 2 months ago
U.S. administration wants a quick deal with Iran: Barclays

U.S. administration wants a quick deal with Iran: Barclays

Mitul Kotecha of Barclays sees no signs of an 'obvious off-ramp' between the U.S. and Iran despite the discussions. He says major central banks are turning hawkish, and sees 'pain' for countries who are energy importers.

Youtube | 2 months ago
Why Barclays Thinks Ionis Is Headed for a 45% Surge From $73 to $106

Why Barclays Thinks Ionis Is Headed for a 45% Surge From $73 to $106

Ionis Pharmaceuticals (NASDAQ:IONS) has delivered a remarkable 137.52% gain over the past year, though the stock has pulled back 6.12% year-to-date and sits 7.20% below its one-month high, currently trading near $72.70.

247wallst | 2 months ago
Barclays sees 13–14 million bpd oil supply loss from prolonged Hormuz disruption

Barclays sees 13–14 million bpd oil supply loss from prolonged Hormuz disruption

Barclays said on Thursday that a prolonged closure of the Strait of Hormuz would likely lead to a 13-14 million barrels per day supply loss, ​noting that while the scale of the disruption is immense, so ‌is the uncertainty around its duration.

Reuters | 2 months ago
Molson Coors Could Drop Another 3% as Barclays Slashes Target to $40 With Underweight Rating

Molson Coors Could Drop Another 3% as Barclays Slashes Target to $40 With Underweight Rating

Molson Coors (NYSE:TAP) has been under sustained pressure heading into 2026.

247wallst | 2 months ago
Carnival Stock Cut by Barclays and Truist, but This Wall Street Pro Still Sees Upside

Carnival Stock Cut by Barclays and Truist, but This Wall Street Pro Still Sees Upside

Carnival Corporation (NYSE:CCL) is heading into its March 27 Q1 2026 earnings report with two Wall Street firms moving in the same direction on price targets but landing in very different places on conviction.

247wallst | 2 months ago
Barclays PLC (BCS) Presents at European Financials Conference 2026 Transcript

Barclays PLC (BCS) Presents at European Financials Conference 2026 Transcript

Barclays PLC (BCS) Presents at European Financials Conference 2026 Transcript

Seekingalpha | 2 months ago
EU Banks Get Breathing Room as Capital Rule Decisions Face Delays

EU Banks Get Breathing Room as Capital Rule Decisions Face Delays

EU delays FRTB capital rules again, giving DB, BCS and BNPQY near-term relief while uncertainty lingers over Basel III rollout.

Zacks | 2 months ago
Barclays raises 2026 Brent forecast to $85 a barrel on Strait of Hormuz disruption

Barclays raises 2026 Brent forecast to $85 a barrel on Strait of Hormuz disruption

Barclays on Friday raised its 2026 Brent crude forecast to $85 per barrel, ​citing ongoing supply disruptions linked to the ‌Iran war that have sharply reduced oil flows through the Strait of Hormuz.

Reuters | 2 months ago
Just Buy It? Barclays Thinks Nike Is Ready to Run

Just Buy It? Barclays Thinks Nike Is Ready to Run

For months, investors have watched Nike, Inc. NYSE: NKE, a titan of the consumer discretionary world, struggle to find its footing, testing the patience of even its most loyal shareholders. The stock's persistent underperformance has been a key storyline.

Marketbeat | 2 months ago
Nike's Stock Gets an Upgrade. Barclays Says It's Likely Reached a 'Fundamental Bottom.

Nike's Stock Gets an Upgrade. Barclays Says It's Likely Reached a 'Fundamental Bottom.

Nike's stock could soon be due for a rebound, according to analysts at Barclays.

Investopedia | 2 months ago
Loading...
Load More